Julio Flores-Gonzalez

8PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersHuman impacts of climate change and human adaptationCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 31, 2025
OPG and TNFR1 as Potential Biomarkers of Inflammation in Older Adults with Acute COVID-19 and Indicators of Frailty in Post-COVID-19: A Pilot Study.

Lucero A Ramon-Luing, Julio Flores-Gonzalez, Daniela Josefina Cataneo-Piña

|Oct 26, 2024
Variants rs3804099 and rs3804100 in the TLR2 Gene Induce Different Profiles of TLR-2 Expression and Cytokines in Response to Spike of SARS-CoV-2.

Julio Flores-González, Zurisadai Monroy-Rodríguez, Ramcés Falfán-Valencia

|Oct 31, 2023
Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patients.

Lucero A Ramon-Luing, Julio Flores-Gonzalez, Luis Angel García-Rojas

|Jun 28, 2023
Latent Tuberculosis Patients Have an Increased Frequency of IFN-γ-Producing CD5+ B Cells, Which Respond Efficiently to Mycobacterial Proteins.

Julio Flores-Gonzalez, Lucero A Ramón-Luing, Jesus Romero-Tendilla

|May 28, 2022
Diverse Cell Death Mechanisms Are Simultaneously Activated in Macrophages Infected by Virulent Mycobacterium tuberculosis.

Lucero A Ramon-Luing, Yessica Olvera, Julio Flores-Gonzalez

|Jan 21, 2022
Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients.

Julio Flores-Gonzalez, Lucero A Ramon-Luing, Ranferi Ocaña-Guzman

Pageof 2

Frequent Collaborators

7 joint publications

Leslie Chavez-Galan

4 joint publications

Lucero A Ramon-Luing

3 joint publications

Ivette Buendia-Roldan

2 joint publications

Ramcés Falfán-Valencia